Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Myron Levin to Herpesvirus 3, Human

This is a "connection" page, showing publications Myron Levin has written about Herpesvirus 3, Human.

 
Connection Strength
  
 
 
12.682
  
  1. Schmid DS, Miao C, Leung J, Johnson M, Weinberg A, Levin MJ. Comparative Antibody Responses to the Live-Attenuated and Recombinant Herpes Zoster Vaccines. J Virol. 2021 05 24; 95(12).
    View in: PubMed
    Score: 0.563
  2. Weinberg A, Pang L, Johnson MJ, Caldas Y, Cho A, Tovar-Salazar A, Canniff J, Schmader KE, Popmihajlov Z, Levin MJ. The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity. J Virol. 2019 08 01; 93(15).
    View in: PubMed
    Score: 0.496
  3. Heineman TC, Cunningham A, Levin M. Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine. Curr Opin Immunol. 2019 08; 59:42-48.
    View in: PubMed
    Score: 0.487
  4. Weinberg A, Popmihajlov Z, Schmader KE, Johnson MJ, Caldas Y, Salazar AT, Canniff J, McCarson BJ, Martin J, Pang L, Levin MJ. Persistence of Varicella-Zoster Virus Cell-Mediated Immunity After the Administration of a Second Dose of Live Herpes Zoster Vaccine. J Infect Dis. 2019 01 07; 219(2):335-338.
    View in: PubMed
    Score: 0.478
  5. Levin MJ, Kroehl ME, Johnson MJ, Hammes A, Reinhold D, Lang N, Weinberg A. Th1 memory differentiates recombinant from live herpes zoster vaccines. J Clin Invest. 2018 10 01; 128(10):4429-4440.
    View in: PubMed
    Score: 0.463
  6. Levin MJ, Cai GY, Lee KS, Rouphael NG, Mehta AK, Canniff J, Mulligan MJ, Weinberg A. Varicella-Zoster Virus DNA in Blood After Administration of Herpes Zoster Vaccine. J Infect Dis. 2018 03 13; 217(7):1055-1059.
    View in: PubMed
    Score: 0.451
  7. Weinberg A, Canniff J, Rouphael N, Mehta A, Mulligan M, Whitaker JA, Levin MJ. Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults. J Immunol. 2017 07 15; 199(2):604-612.
    View in: PubMed
    Score: 0.429
  8. Levin MJ, Weinberg A, Schmid DS. Herpes Simplex Virus and Varicella-Zoster Virus. Microbiol Spectr. 2016 06; 4(3).
    View in: PubMed
    Score: 0.399
  9. Levin MJ, Schmader KE, Pang L, Williams-Diaz A, Zerbe G, Canniff J, Johnson MJ, Caldas Y, Cho A, Lang N, Su SC, Parrino J, Popmihajlov Z, Weinberg A. Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults. J Infect Dis. 2016 Jan 01; 213(1):14-22.
    View in: PubMed
    Score: 0.382
  10. Levin MJ. Varicella-zoster virus and virus DNA in the blood and oropharynx of people with latent or active varicella-zoster virus infections. J Clin Virol. 2014 Dec; 61(4):487-95.
    View in: PubMed
    Score: 0.356
  11. Chen SY, Suaya JA, Li Q, Galindo CM, Misurski D, Burstin S, Levin MJ. Incidence of herpes zoster in patients with altered immune function. Infection. 2014 Apr; 42(2):325-34.
    View in: PubMed
    Score: 0.334
  12. Levin MJ, Schmader KE, Gnann JW, McNeil SA, Vesikari T, Betts RF, Keay S, Stek JE, Bundick ND, Su SC, Zhao Y, Li X, Chan IS, Annunziato PW, Parrino J. Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine. J Infect Dis. 2013 Nov 01; 208(9):1386-90.
    View in: PubMed
    Score: 0.328
  13. Lee KS, Zhou W, Scott-McKean JJ, Emmerling KL, Cai GY, Krah DL, Costa AC, Freed CR, Levin MJ. Human sensory neurons derived from induced pluripotent stem cells support varicella-zoster virus infection. PLoS One. 2012; 7(12):e53010.
    View in: PubMed
    Score: 0.315
  14. Levin MJ. Immune senescence and vaccines to prevent herpes zoster in older persons. Curr Opin Immunol. 2012 Aug; 24(4):494-500.
    View in: PubMed
    Score: 0.306
  15. Tyring SK, Stek JE, Smith JG, Xu J, Pagnoni M, Chan IS, Silber JL, Parrino J, Levin MJ. Varicella-zoster virus-specific enzyme-linked immunospot assay responses and zoster-associated pain in herpes zoster subjects. Clin Vaccine Immunol. 2012 Sep; 19(9):1411-5.
    View in: PubMed
    Score: 0.305
  16. Weinberg A, Huang S, Song LY, Fenton T, Williams P, Patterson J, Tovar-Salazar A, Levin MJ. Immune correlates of herpes zoster in HIV-infected children and youth. J Virol. 2012 Mar; 86(5):2878-81.
    View in: PubMed
    Score: 0.293
  17. Frazer IH, Levin MJ. Paradigm shifting vaccines: prophylactic vaccines against latent varicella-zoster virus infection and against HPV-associated cancer. Curr Opin Virol. 2011 Oct; 1(4):268-79.
    View in: PubMed
    Score: 0.289
  18. Levin MJ, Gershon AA, Dworkin RH, Brisson M, Stanberry L. Prevention strategies for herpes zoster and post-herpetic neuralgia. J Clin Virol. 2010 May; 48 Suppl 1:S14-9.
    View in: PubMed
    Score: 0.262
  19. Weinberg A, Lazar AA, Zerbe GO, Hayward AR, Chan IS, Vessey R, Silber JL, MacGregor RR, Chan K, Gershon AA, Levin MJ. Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses. J Infect Dis. 2010 Apr 01; 201(7):1024-30.
    View in: PubMed
    Score: 0.260
  20. Weinberg A, Levin MJ. VZV T cell-mediated immunity. Curr Top Microbiol Immunol. 2010; 342:341-57.
    View in: PubMed
    Score: 0.256
  21. Levin MJ, Anderson JP, Seage GR, Williams PL. Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children. J Acquir Immune Defic Syndr. 2009 Feb 01; 50(2):182-91.
    View in: PubMed
    Score: 0.240
  22. Levin MJ, DeBiasi RL, Bostik V, Schmid DS. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine. J Infect Dis. 2008 Nov 15; 198(10):1444-7.
    View in: PubMed
    Score: 0.237
  23. Levin MJ, Oxman MN, Zhang JH, Johnson GR, Stanley H, Hayward AR, Caulfield MJ, Irwin MR, Smith JG, Clair J, Chan IS, Williams H, Harbecke R, Marchese R, Straus SE, Gershon A, Weinberg A. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis. 2008 Mar 15; 197(6):825-35.
    View in: PubMed
    Score: 0.226
  24. Johnson R, McElhaney J, Pedalino B, Levin M. Prevention of herpes zoster and its painful and debilitating complications. Int J Infect Dis. 2007 Nov; 11 Suppl 2:S43-8.
    View in: PubMed
    Score: 0.220
  25. Finnen RL, Mizokami KR, Banfield BW, Cai GY, Simpson SA, Pizer LI, Levin MJ. Postentry events are responsible for restriction of productive varicella-zoster virus infection in Chinese hamster ovary cells. J Virol. 2006 Nov; 80(21):10325-34.
    View in: PubMed
    Score: 0.205
  26. Weinberg A, Wiznia AA, LaFleur BJ, Shah S, Levin MJ. Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis. 2004 Jul 15; 190(2):267-70.
    View in: PubMed
    Score: 0.174
  27. Levin MJ, Ginde AA, Schmid DS, Lang N, Canniff J, Schwartz RS, Weinberg A. Effect of high dose vitamin D supplementation on subsequent immune responses to administration of the live herpes zoster vaccine to long-term care residents. Vaccine. 2024 Apr 02; 42(9):2278-2281.
    View in: PubMed
    Score: 0.171
  28. Weinberg A, Scott Schmid D, Leung J, Johnson MJ, Miao C, Levin MJ. Predictors of 5-Year Persistence of Antibody Responses to Zoster Vaccines. J Infect Dis. 2023 11 11; 228(10):1367-1374.
    View in: PubMed
    Score: 0.167
  29. Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan IS, Li DJ, Wang W, Keller PM, Shaw A, Silber JL, Schlienger K, Chalikonda I, Vessey SJ, Caulfield MJ. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis. 2003 Nov 01; 188(9):1336-44.
    View in: PubMed
    Score: 0.166
  30. Levin MJ, Dahl KM, Weinberg A, Giller R, Patel A, Krause PR. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child. J Infect Dis. 2003 Oct 01; 188(7):954-9.
    View in: PubMed
    Score: 0.166
  31. Levin MJ, Cai GY, Manchak MD, Pizer LI. Varicella-zoster virus DNA in cells isolated from human trigeminal ganglia. J Virol. 2003 Jun; 77(12):6979-87.
    View in: PubMed
    Score: 0.162
  32. Levin MJ, Weinberg A. Immune Responses to Varicella-Zoster Virus Vaccines. Curr Top Microbiol Immunol. 2023; 438:223-246.
    View in: PubMed
    Score: 0.157
  33. Levin MJ, Weinberg A. Adjuvanted Recombinant Glycoprotein E Herpes Zoster Vaccine. Clin Infect Dis. 2020 03 17; 70(7):1509-1515.
    View in: PubMed
    Score: 0.130
  34. Harbecke R, Jensen NJ, Depledge DP, Johnson GR, Ashbaugh ME, Schmid DS, Breuer J, Levin MJ, Oxman MN. Recurrent herpes zoster in the Shingles Prevention Study: Are second episodes caused by the same varicella-zoster virus strain? Vaccine. 2020 01 10; 38(2):150-157.
    View in: PubMed
    Score: 0.126
  35. Graybill C, Morgan MJ, Levin MJ, Lee KS. Varicella-zoster virus inhibits autophagosome-lysosome fusion and the degradation stage of mTOR-mediated autophagic flux. Virology. 2018 09; 522:220-227.
    View in: PubMed
    Score: 0.116
  36. Cunningham AL, Heineman TC, Lal H, Godeaux O, Chlibek R, Hwang SJ, McElhaney JE, Vesikari T, Andrews C, Choi WS, Esen M, Ikematsu H, Choma MK, Pauksens K, Ravault S, Salaun B, Schwarz TF, Smetana J, Abeele CV, Van den Steen P, Vastiau I, Weckx LY, Levin MJ. Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older. J Infect Dis. 2018 05 05; 217(11):1750-1760.
    View in: PubMed
    Score: 0.114
  37. Graybill C, Claypool DJ, Brinton JT, Levin MJ, Lee KS. Cytokines Produced in Response to Varicella-Zoster Virus Infection of ARPE-19 Cells Stimulate Lymphocyte Chemotaxis. J Infect Dis. 2017 11 15; 216(8):1038-1047.
    View in: PubMed
    Score: 0.110
  38. Levin MJ, Buchwald UK, Gardner J, Martin J, Stek JE, Brown E, Popmihajlov Z. Immunogenicity and safety of zoster vaccine live administered with quadrivalent influenza virus vaccine. Vaccine. 2018 01 02; 36(1):179-185.
    View in: PubMed
    Score: 0.109
  39. Beals CR, Railkar RA, Schaeffer AK, Levin Y, Kochba E, Meyer BK, Evans RK, Sheldon EA, Lasseter K, Lang N, Weinberg A, Canniff J, Levin MJ. Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trial. Lancet Infect Dis. 2016 08; 16(8):915-22.
    View in: PubMed
    Score: 0.099
  40. Weinberg A, Hayward AR, Masters HB, Ogu IA, Levin MJ. Comparison of two methods for detecting varicella-zoster virus antibody with varicella-zoster virus cell-mediated immunity. J Clin Microbiol. 1996 Feb; 34(2):445-6.
    View in: PubMed
    Score: 0.098
  41. Hayward AR, Buda K, Jones M, White CJ, Levin MJ. Varicella zoster virus-specific cytotoxicity following secondary immunization with live or killed vaccine. Viral Immunol. 1996; 9(4):241-5.
    View in: PubMed
    Score: 0.097
  42. Levin MJ, Rotbart HA, Hayward AR. Immune response to varicella-zoster virus 5 years after acyclovir therapy of childhood varicella. J Infect Dis. 1995 May; 171(5):1383-4.
    View in: PubMed
    Score: 0.093
  43. Arvin AM, Wolinsky JS, Kappos L, Morris MI, Reder AT, Tornatore C, Gershon A, Gershon M, Levin MJ, Bezuidenhoudt M, Putzki N. Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management. JAMA Neurol. 2015 Jan; 72(1):31-9.
    View in: PubMed
    Score: 0.090
  44. Hayward AR, Zerbe GO, Levin MJ. Clinical application of responder cell frequency estimates with four years of follow up. J Immunol Methods. 1994 Mar 29; 170(1):27-36.
    View in: PubMed
    Score: 0.086
  45. Chiu C, McCausland M, Sidney J, Duh FM, Rouphael N, Mehta A, Mulligan M, Carrington M, Wieland A, Sullivan NL, Weinberg A, Levin MJ, Pulendran B, Peters B, Sette A, Ahmed R. Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV. PLoS Pathog. 2014 Mar; 10(3):e1004008.
    View in: PubMed
    Score: 0.086
  46. Somekh E, Levin MJ. Infection of human fetal dorsal root neurons with wild type varicella virus and the Oka strain varicella vaccine. J Med Virol. 1993 Jul; 40(3):241-3.
    View in: PubMed
    Score: 0.081
  47. Irwin MR, Levin MJ, Laudenslager ML, Olmstead R, Lucko A, Lang N, Carrillo C, Stanley HA, Caulfield MJ, Weinberg A, Chan IS, Clair J, Smith JG, Marchese RD, Williams HM, Beck DJ, McCook PT, Zhang JH, Johnson G, Oxman MN. Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications. Clin Infect Dis. 2013 Apr; 56(8):1085-93.
    View in: PubMed
    Score: 0.079
  48. Somekh E, Tedder DG, Vafai A, Assouline JG, Straus SE, Wilcox CL, Levin MJ. Latency in vitro of varicella-zoster virus in cells derived from human fetal dorsal root ganglia. Pediatr Res. 1992 Dec; 32(6):699-703.
    View in: PubMed
    Score: 0.078
  49. Levin MJ, Murray M, Rotbart HA, Zerbe GO, White CJ, Hayward AR. Immune response of elderly individuals to a live attenuated varicella vaccine. J Infect Dis. 1992 Aug; 166(2):253-9.
    View in: PubMed
    Score: 0.076
  50. Irwin MR, Levin MJ, Carrillo C, Olmstead R, Lucko A, Lang N, Caulfield MJ, Weinberg A, Chan IS, Clair J, Smith JG, Marchese RD, Williams HM, Beck DJ, McCook PT, Johnson G, Oxman MN. Major depressive disorder and immunity to varicella-zoster virus in the elderly. Brain Behav Immun. 2011 May; 25(4):759-66.
    View in: PubMed
    Score: 0.069
  51. Gershon AA, Gershon MD, Breuer J, Levin MJ, Oaklander AL, Griffiths PD. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol. 2010 May; 48 Suppl 1:S2-7.
    View in: PubMed
    Score: 0.065
  52. Weinberg A, Zhang JH, Oxman MN, Johnson GR, Hayward AR, Caulfield MJ, Irwin MR, Clair J, Smith JG, Stanley H, Marchese RD, Harbecke R, Williams HM, Chan IS, Arbeit RD, Gershon AA, Sch?del F, Morrison VA, Kauffman CA, Straus SE, Schmader KE, Davis LE, Levin MJ. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis. 2009 Oct 01; 200(7):1068-77.
    View in: PubMed
    Score: 0.063
  53. Harbecke R, Oxman MN, Arnold BA, Ip C, Johnson GR, Levin MJ, Gelb LD, Schmader KE, Straus SE, Wang H, Wright PF, Pachucki CT, Gershon AA, Arbeit RD, Davis LE, Simberkoff MS, Weinberg A, Williams HM, Cheney C, Petrukhin L, Abraham KG, Shaw A, Manoff S, Antonello JM, Green T, Wang Y, Tan C, Keller PM. A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. J Med Virol. 2009 Jul; 81(7):1310-22.
    View in: PubMed
    Score: 0.062
  54. Gershon AA, Levin MJ, Weinberg A, Song LY, LaRussa PS, Steinberg SP, Bartlett P. A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella. Pediatr Infect Dis J. 2009 Jul; 28(7):653-5.
    View in: PubMed
    Score: 0.062
  55. Rabalais GP, Berkowitz FE, Hayward AR, Levin MJ. Inhibition of varicella-zoster virus in vitro by human peripheral blood mononuclear cells. Clin Exp Immunol. 1989 Mar; 75(3):381-6.
    View in: PubMed
    Score: 0.060
  56. Levin MJ. Varicella vaccination of immunocompromised children. J Infect Dis. 2008 Mar 01; 197 Suppl 2:S200-6.
    View in: PubMed
    Score: 0.056
  57. Pellissier JM, Brisson M, Levin MJ. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Vaccine. 2007 Nov 28; 25(49):8326-37.
    View in: PubMed
    Score: 0.055
  58. McGregor JA, Mark S, Crawford GP, Levin MJ. Varicella zoster antibody testing in the care of pregnant women exposed to varicella. Am J Obstet Gynecol. 1987 Aug; 157(2):281-4.
    View in: PubMed
    Score: 0.054
  59. Loparev VN, Rubtcova E, Seward JF, Levin MJ, Schmid DS. DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine. J Infect Dis. 2007 Feb 15; 195(4):502-10.
    View in: PubMed
    Score: 0.052
  60. Wang JP, Kurt-Jones EA, Shin OS, Manchak MD, Levin MJ, Finberg RW. Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2. J Virol. 2005 Oct; 79(20):12658-66.
    View in: PubMed
    Score: 0.048
  61. Berkowitz FE, Levin MJ. Use of an enzyme-linked immunosorbent assay performed directly on fixed infected cell monolayers for evaluating drugs against varicella-zoster virus. Antimicrob Agents Chemother. 1985 Aug; 28(2):207-10.
    View in: PubMed
    Score: 0.047
  62. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005 Jun 02; 352(22):2271-84.
    View in: PubMed
    Score: 0.047
  63. Levin MJ, Leventhal S, Masters HA. Factors influencing quantitative isolation of varicella-zoster virus. J Clin Microbiol. 1984 Jun; 19(6):880-3.
    View in: PubMed
    Score: 0.043
  64. Laing KJ, Ford ES, Johnson MJ, Levin MJ, Koelle DM, Weinberg A. Recruitment of naive CD4+ T cells by the recombinant zoster vaccine correlates with persistent immunity. J Clin Invest. 2023 12 01; 133(23).
    View in: PubMed
    Score: 0.042
  65. Smith JG, Levin M, Vessey R, Chan IS, Hayward AR, Liu X, Kaufhold RM, Clair J, Chalikonda I, Chan C, Bernard M, Wang WW, Keller P, Caulfield MJ. Measurement of cell-mediated immunity with a Varicella-Zoster Virus-specific interferon-gamma ELISPOT assay: responses in an elderly population receiving a booster immunization. J Med Virol. 2003; 70 Suppl 1:S38-41.
    View in: PubMed
    Score: 0.039
  66. Johnson MJ, Liu C, Ghosh D, Lang N, Levin MJ, Weinberg A. Cell-Mediated Immune Responses After Administration of the Live or the Recombinant Zoster Vaccine: 5-Year Persistence. J Infect Dis. 2022 04 19; 225(8):1477-1481.
    View in: PubMed
    Score: 0.037
  67. Arbeit RD, Zaia JA, Valerio MA, Levin MJ. Infection of human peripheral blood mononuclear cells by varicella-zoster virus. Intervirology. 1982; 18(1-2):56-65.
    View in: PubMed
    Score: 0.037
  68. Colindres R, Wascotte V, Brecx A, Clarke C, Herv? C, Kim JH, Levin MJ, Oostvogels L, Zahaf T, Schuind A, Cunningham AL. Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials. Hum Vaccin Immunother. 2020 11 01; 16(11):2628-2633.
    View in: PubMed
    Score: 0.033
  69. Hayward AR, Cosyns M, Jones M, Levin MJ, Villanueba E, Weinberg A, Chan CY. Cytokine production in varicella-zoster virus-stimulated cultures of human blood lymphocytes. J Infect Dis. 1998 Nov; 178 Suppl 1:S95-8.
    View in: PubMed
    Score: 0.029
  70. Irwin M, Costlow C, Williams H, Artin KH, Chan CY, Stinson DL, Levin MJ, Hayward AR, Oxman MN. Cellular immunity to varicella-zoster virus in patients with major depression. J Infect Dis. 1998 Nov; 178 Suppl 1:S104-8.
    View in: PubMed
    Score: 0.029
  71. Levin MJ, Barber D, Goldblatt E, Jones M, LaFleur B, Chan C, Stinson D, Zerbe GO, Hayward AR. Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect. J Infect Dis. 1998 Nov; 178 Suppl 1:S109-12.
    View in: PubMed
    Score: 0.029
  72. Zhang Y, Cosyns M, Levin MJ, Hayward AR. Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin Exp Immunol. 1994 Oct; 98(1):128-33.
    View in: PubMed
    Score: 0.022
  73. Hayward AR, Buda K, Levin MJ. Immune response to secondary immunization with live or inactivated VZV vaccine in elderly adults. Viral Immunol. 1994; 7(1):31-6.
    View in: PubMed
    Score: 0.021
  74. Silliman CC, Tedder D, Ogle JW, Simon J, Kleinschmidt-DeMasters BK, Manco-Johnson M, Levin MJ. Unsuspected varicella-zoster virus encephalitis in a child with acquired immunodeficiency syndrome. J Pediatr. 1993 Sep; 123(3):418-22.
    View in: PubMed
    Score: 0.021
  75. Drolet M, Oxman MN, Levin MJ, Schmader KE, Johnson RW, Patrick D, Mansi JA, Brisson M. Vaccination against herpes zoster in developed countries: state of the evidence. Hum Vaccin Immunother. 2013 May; 9(5):1177-84.
    View in: PubMed
    Score: 0.020
  76. Vermeulen JN, Lange JM, Tyring SK, Peters PH, Nunez M, Poland G, Levin MJ, Freeman C, Chalikonda I, Li J, Smith JG, Caulfield MJ, Stek JE, Chan IS, Vessey R, Sch?del FP, Annunziato PW, Schlienger K, Silber JL. Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults =60 years of age. Vaccine. 2012 Jan 20; 30(5):904-10.
    View in: PubMed
    Score: 0.018
  77. Assouline JG, Levin MJ, Major EO, Forghani B, Straus SE, Ostrove JM. Varicella-zoster virus infection of human astrocytes, Schwann cells, and neurons. Virology. 1990 Dec; 179(2):834-44.
    View in: PubMed
    Score: 0.017
  78. Oxman MN, Levin MJ. Vaccination against Herpes Zoster and Postherpetic Neuralgia. J Infect Dis. 2008 Mar 01; 197 Suppl 2:S228-36.
    View in: PubMed
    Score: 0.014
  79. Pontesilli O, Carotenuto P, Levin MJ, Suez D, Hayward AR. Processing and presentation of cell-associated varicella-zoster virus antigens by human monocytes. Clin Exp Immunol. 1987 Oct; 70(1):127-35.
    View in: PubMed
    Score: 0.014
  80. Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, Betts RF, Gershon AA, Haanpaa ML, McKendrick MW, Nurmikko TJ, Oaklander AL, Oxman MN, Pavan-Langston D, Petersen KL, Rowbotham MC, Schmader KE, Stacey BR, Tyring SK, van Wijck AJ, Wallace MS, Wassilew SW, Whitley RJ. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007 Jan 01; 44 Suppl 1:S1-26.
    View in: PubMed
    Score: 0.013
  81. Giller RH, Bowden RA, Levin MJ, Walker LJ, Tubergen DG, Hayward AR. Reduced cellular immunity to varicella zoster virus during treatment for acute lymphoblastic leukemia of childhood: in vitro studies of possible mechanisms. J Clin Immunol. 1986 Nov; 6(6):472-80.
    View in: PubMed
    Score: 0.013
  82. Bowden RA, Levin MJ, Giller RH, Tubergen DG, Hayward AR. Lysis of varicella zoster virus infected cells by lymphocytes from normal humans and immunosuppressed pediatric leukaemic patients. Clin Exp Immunol. 1985 May; 60(2):387-95.
    View in: PubMed
    Score: 0.012
  83. Levin MJ, Leary PL. Inhibition of human herpesviruses by combination of acyclovir and human leukocyte interferon. Infect Immun. 1981 Jun; 32(3):995-9.
    View in: PubMed
    Score: 0.009
  84. Levin MJ, Rinaldo CR, Leary PL, Zaia JA, Hirsch MS. Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis. J Infect Dis. 1979 Dec; 140(6):851-7.
    View in: PubMed
    Score: 0.008
  85. Zaia JA, Levin MJ, Wright GG, Grady GF. A practical method for preparation of varicella-zoster immune globulin. J Infect Dis. 1978 May; 137(5):601-4.
    View in: PubMed
    Score: 0.007
  86. Rotbart HA, Levin MJ, Hayward AR. Immune responses to varicella zoster virus infections in healthy children. J Infect Dis. 1993 Jan; 167(1):195-9.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)